| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Stuelpnagel John R is a Director at 10x Genomics, Inc.. Recent SEC Form 4 filings include 0 buys and 28 sells.
Estimated insider holdings value: $7.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2020 | TXG 10x Genomics, Inc. | Director | Sell | 7,500 | $125.60 | $941,981.13 | -0.4% | |
| Sep 16, 2020 | TXG 10x Genomics, Inc. | Director | Sell | 7,500 | $121.63 | $912,203.66 | -0.3% | |
| Sep 1, 2020 | TXG 10x Genomics, Inc. | Director | Sell | 7,500 | $113.92 | $854,405.13 | -0.3% | |
| Aug 17, 2020 | TXG 10x Genomics, Inc. | Director | Sell | 7,500 | $104.67 | $785,060.80 | -0.5% | |
| Aug 3, 2020 | TXG 10x Genomics, Inc. | Director | Sell | 7,500 | $99.34 | $745,046.59 | -0.4% | |
| Jul 16, 2020 | TXG 10x Genomics, Inc. | Director | Sell | 7,500 | $88.86 | $666,426.52 | -0.4% | |
| Jul 1, 2020 | TXG 10x Genomics, Inc. | Director | Sell | 7,500 | $87.58 | $656,813.19 | -0.4% | |
| Jun 17, 2020 | TXG 10x Genomics, Inc. | Director | Sell | 7,500 | $89.14 | $668,558.01 | -0.4% |